XOMA Corporation

NasdaqGM XOMA

XOMA Corporation Total Assets for the quarter ending September 30, 2024: USD 223.34 M

XOMA Corporation Total Assets is USD 223.34 M for the quarter ending September 30, 2024, a 79.98% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.

XOMA Corporation Total Assets for the quarter ending September 30, 2023 was USD 124.09 M, a -15.08% change year over year.
XOMA Corporation Total Assets for the quarter ending September 30, 2022 was USD 146.13 M, a 11.98% change year over year.
XOMA Corporation Total Assets for the quarter ending September 30, 2021 was USD 130.50 M, a 52.23% change year over year.
XOMA Corporation Total Assets for the quarter ending September 30, 2020 was USD 85.73 M, a -0.43% change year over year.

Key data

Date	Total Assets	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity

NasdaqGM: XOMA

XOMA Corporation

CEO	Mr. Owen P. Hughes Jr.
IPO Date	June 6, 1986
Location	United States
Headquarters	2200 Powell Street
Employees	13
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Key trends

Past 5 years